Pinuccia Valagussa

8PUBLICATIONS
94CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 04, 2025
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies.

Maurizio Callari, Matteo Dugo, Marco Barreca

|Oct 25, 2024
Development and validation of a gene expression-based Breast Cancer Purity Score.

Marco Barreca, Matteo Dugo, Barbara Galbardi

|Sep 23, 2024
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle

|Sep 06, 2023
Spatial predictors of immunotherapy response in triple-negative breast cancer.

Xiao Qian Wang, Esther Danenberg, Chiun-Sheng Huang

|Aug 09, 2023
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.

Georg Pfeiler, Dominik Hlauschek, Erica L Mayer

|Apr 19, 2023
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.

Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch

Pageof 2

Frequent Collaborators

4 joint publications

Giampaolo Bianchini

3 joint publications

Lucia Del Mastro

3 joint publications

Javier Cortes

3 joint publications

Sibylle Loibl